eNauka - pregled
Pregled prema Projekat Biogen (Cambridge, MA, USA)
Prikaz rezultata 1 do 4 od 4
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2020 | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study | Naismith, Robert T; ...; Obradovic, Dragana V; ...; (broj, koautora 20) | Naučni članak | 21M21 - Rad u vrhunskom međ. časopisu |
| 2019 | Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: interim safety and efficacy results from the Phase 3 EVOLVE-MS-1 study | Bergh, Florian Then; Singer, BA; Drulovic, Jelena S   ; Bidollari, I; Chen, Hailu; Englishby, R; Hanna, Jerome; Kandinov, Boris; Lopez-Bresnahan, Maria; Leigh-Pemberton, Richard;
Miller, Catherine; Mokliatchouk, O; Shafer, SJ;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2016 | Efficacy analysis of opicinumab in relapsing multiple sclerosis: the Phase 2b SYNERGY trial. | Cadaviv, Diego; Edwards, KR; Hupperts, Raymond; Drulovic, Jelena S ; Montalban, Xavier; Hartung, H-P; Brochet, B; Calabresi, PA; Rudick, R; Ibrahim, Adama;
Zhang, Yiwei; Xu, Lei;
| Konferencijski rad | Mp kategorija će biti prikazana naknadno. |
| 2022 | Efficacy and Safety Outcomes with Diroximel Fumarate After Switching from Prior Therapies or Continuing on DRF: Results from the Phase 3 EVOLVE-MS-1 Study (✓) | Wray, Sibyl; ...; Drulović, Jelena S. ; ...; (broj koautora 17) | Naučni članak | 22M22 - Rad u istaknutom međ. časopisu |